Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CORTISS: Success Rates and Safety in Managing Spinal and Sacro-Iliac Pain
NCT07762170Phase 4Recruiting
- Start
- Jul 2026
- Primary completion
- Dec 2029
- Countries
- 1
01
Overview
A Phase 4 trial of methylprednisolone, betamethasone, dexamethasone, triamcinolone acetonide in back pain, Cervicalgia, radiculopathy, spinal stenosis, failed back surgery syndrome (FBSS). Started Jul 2026; status: recruiting.
02
Drugs
methylprednisolonebetamethasonedexamethasonetriamcinolone acetonide
03
Conditions
back painCervicalgiaradiculopathyspinal stenosisfailed back surgery syndrome (FBSS)
Beyond the preview
Go deeper on NCT07762170.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07762170.